Yi-Wen Lin Selected Research

Electroacupuncture

1/2022	Optogenetic modulation of electroacupuncture analgesia in a mouse inflammatory pain model.
1/2022	Electroacupuncture Reduces Fibromyalgia Pain by Attenuating the HMGB1, S100B, and TRPV1 Signalling Pathways in the Mouse Brain.
1/2022	Electroacupuncture reduces mice inflammatory pain through adiponectin in the peripheral circulation and the central spinal cord.
10/2021	Transient receptor potential V1 modulates neuroinflammation in Parkinson's disease dementia: Molecular implications for electroacupuncture and rivastigmine.
6/2021	Electroacupuncture reduces cold stress-induced pain through microglial inactivation and transient receptor potential V1 in mice.
5/2021	TRPV1 Responses in the Cerebellum Lobules VI, VII, VIII Using Electroacupuncture Treatment for Chronic Pain and Depression Comorbidity in a Murine Model.
1/2021	Functional characterization of nociceptive mechanisms involved in fibromyalgia and electroacupuncture.
1/2021	Electroacupuncture Attenuates Chronic Inflammatory Pain and Depression Comorbidity through Transient Receptor Potential V1 in the Brain.
10/2020	Transient receptor potential V1 (TRPV1) modulates the therapeutic effects for comorbidity of pain and depression: The common molecular implication for electroacupuncture and omega-3 polyunsaturated fatty acids.
7/2020	Electroacupuncture reduces chronic fibromyalgia pain through attenuation of transient receptor potential vanilloid 1 signaling pathway in mouse brains.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yi-Wen Lin Research Topics

Disease

33	Pain (Aches) 04/2022 - 11/2011
21	Inflammation (Inflammations) 05/2022 - 12/2006
19	Hyperalgesia 04/2022 - 01/2009
18	Neoplasms (Cancer) 01/2021 - 11/2003
12	Fibromyalgia (Fibrositis) 01/2022 - 01/2015
7	Chronic Pain 04/2022 - 01/2015
7	Atherosclerosis 05/2021 - 12/2006
5	Neuralgia (Stump Neuralgia) 04/2022 - 01/2014
5	Parkinson Disease (Parkinson's Disease) 02/2022 - 04/2017
5	Infections 10/2021 - 01/2012
4	Cardiovascular Diseases (Cardiovascular Disease) 05/2022 - 01/2015
4	Neuroinflammatory Diseases 10/2021 - 10/2020
4	Neoplasm Metastasis (Metastasis) 05/2021 - 08/2010
4	Seizures (Absence Seizure) 01/2018 - 05/2011
4	Epilepsy (Aura) 01/2017 - 01/2012
4	Ischemia 01/2017 - 06/2014
3	Alzheimer Disease (Alzheimer's Disease) 04/2022 - 05/2021
3	Mitochondrial Diseases (Mitochondrial Disease) 02/2022 - 03/2020
3	Wounds and Injuries (Trauma) 02/2022 - 01/2019
3	Colorectal Neoplasms (Colorectal Cancer) 10/2020 - 01/2016
3	Cerebral Infarction 01/2017 - 01/2012
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 04/2016
3	Breast Neoplasms (Breast Cancer) 12/2005 - 09/2004
2	Renal Insufficiency (Renal Failure) 05/2022 - 10/2021
2	Parkinsonian Disorders (Parkinsonism) 02/2022 - 03/2020
2	Dementia (Dementias) 11/2021 - 10/2021
2	Dyslipidemias (Dyslipidemia) 05/2021 - 01/2019
2	Sarcopenia 04/2021 - 03/2021
2	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2017
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 02/2017
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 05/2019 - 09/2010
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 12/2005
2	Brain Ischemia (Cerebral Ischemia) 11/2018 - 01/2016
2	Infarction (Infarctions) 01/2017 - 01/2016
2	Body Weight (Weight, Body) 12/2015 - 01/2011

Drug/Important Bio-Agent (IBA)

13	Freund's AdjuvantIBA 01/2022 - 01/2009
9	Therapeutic UsesIBA 02/2022 - 06/2005
8	salicylhydroxamic acid (SHAM)IBA 04/2022 - 12/2015
7	AcidsIBA 05/2021 - 01/2012
7	Proteins (Proteins, Gene)FDA Link 07/2020 - 09/2008
6	AntioxidantsIBA 02/2022 - 09/2020
6	Analgesics (Analgesic Drugs)IBA 01/2021 - 01/2012
5	Pharmaceutical PreparationsIBA 01/2021 - 01/2016
5	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 11/2003
5	Toll-Like Receptor 4IBA 01/2018 - 12/2006
5	Kainic Acid (Kainate)IBA 01/2018 - 05/2011
4	Neuroprotective AgentsIBA 04/2022 - 01/2012
4	Ion Channels (Ion Channel)IBA 06/2021 - 01/2009
4	CarrageenanIBA 01/2013 - 01/2009
3	TeaIBA 04/2022 - 09/2020
3	theanineIBA 04/2022 - 09/2020
3	Amino Acids FDA Link 04/2022 - 09/2020
3	Neurotransmitter Agents (Neurotransmitter)IBA 06/2021 - 01/2019
3	Biological ProductsIBA 10/2020 - 04/2015
3	Acid Sensing Ion ChannelsIBA 01/2020 - 01/2009
3	Transient Receptor Potential ChannelsIBA 01/2020 - 07/2010
3	CytokinesIBA 12/2019 - 01/2014
3	Adenosine (Adenocard)FDA LinkGeneric 11/2017 - 01/2017
3	Opioid Analgesics (Opioids)IBA 11/2017 - 01/2017
3	Type II DNA Topoisomerases (Topoisomerase II)IBA 02/2017 - 11/2003
3	indoleIBA 02/2017 - 04/2016
2	HydrogelsIBA 04/2022 - 01/2021
2	CurcuminIBA 04/2022 - 04/2021
2	Interleukin-6 (Interleukin 6)IBA 04/2022 - 11/2021
2	Caspase 3 (Caspase-3)IBA 04/2022 - 08/2010
2	RotenoneIBA 02/2022 - 03/2020
2	erucylphosphocholineIBA 12/2021 - 01/2015
2	Peptides (Polypeptides)IBA 11/2021 - 01/2011
2	Polysaccharides (Glycans)IBA 11/2021 - 03/2021
2	Amyloid (Amyloid Fibrils)IBA 11/2021 - 05/2021
2	HDL LipoproteinsIBA 05/2021 - 01/2019
2	Durapatite (Hydroxylapatite)IBA 04/2021 - 03/2021
2	LipopolysaccharidesIBA 03/2021 - 12/2006
2	Small Interfering RNA (siRNA)IBA 01/2021 - 01/2012
2	Bevacizumab (Avastin)FDA Link 10/2020 - 01/2016
2	Irinotecan (Camptosar)FDA LinkGeneric 10/2020 - 01/2016
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2020 - 01/2015
2	N-Methylaspartate (NMDA)IBA 01/2020 - 09/2010
2	Toll-Like Receptor 2IBA 12/2019 - 01/2016
2	ChemokinesIBA 12/2019 - 01/2017
2	MicroRNAs (MicroRNA)IBA 11/2019 - 01/2019
2	CollagenIBA 01/2019 - 10/2017
2	Glutamic Acid (Glutamate)FDA Link 04/2018 - 01/2015
2	N(6)-cyclopentyladenosineIBA 11/2017 - 01/2017
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2017 - 03/2017
2	trioctyl phosphine oxide (TOPO)IBA 02/2017 - 11/2003
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 01/2016
2	AntigensIBA 01/2016 - 12/2006
2	VaccinesIBA 04/2015 - 01/2015
2	oxidized low density lipoproteinIBA 01/2015 - 04/2011

Therapy/Procedure

38	Electroacupuncture 01/2022 - 09/2010
16	Acupuncture Points (Acupuncture Point) 04/2022 - 09/2010
15	Therapeutics 05/2022 - 08/2010
8	Injections 09/2020 - 01/2015
7	Analgesia 01/2022 - 01/2012
4	Intravenous Injections 01/2016 - 09/2004
3	Transplantation 05/2022 - 11/2019
3	Drug Therapy (Chemotherapy) 01/2017 - 01/2016
2	Sutures (Suture) 05/2019 - 01/2014
2	Precision Medicine 01/2017 - 01/2016